Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Pharmacol.

Sec. Drugs Outcomes Research and Policies

Correction: Methodological Study Protocol for The European Atlas of Clinical Trials in Cancer and Haematology

Provisionally accepted
Merce CasesMerce Cases1*Rachel GilesRachel Giles2*Tamas AghTamas Agh3Maria PigginMaria Piggin4Jan GeisslerJan Geissler1,5Monica RacovitaMonica Racovita6Judit HagymásyJudit Hagymásy3Lora Ruth WoguLora Ruth Wogu7Ákos JózwiakÁkos Józwiak3Albina Hyseni-BocolliAlbina Hyseni-Bocolli8Dalma HosszúDalma Hosszú3,9Ananda PlateAnanda Plate1,2
  • 1European Patient Advocacy Institute, Riemerling, Germany
  • 2VHL Europa, Vlaardingen, Netherlands
  • 3Syreon Research Institute, Budapest, Hungary
  • 4PNH Global Alliance, Tiel, Netherlands
  • 5Workgroup of European Cancer Patient Advocacy Networks, Barcelona, Spain
  • 6Myeloma Patients Europe, Brussels, Belgium
  • 7European Sickle Cell Federation-ESCF, Dublin, Ireland
  • 8Childhood Cancer International – Europe, Vienna, Austria
  • 9University of Pécs Institute of Psychology, Pécs, Hungary

This article is a correction to:

  1. Methodological study protocol for The European Atlas of clinical trials in cancer and haematology

    1. Read original article

The final, formatted version of the article will be published soon.

Select one of your emails

You have multiple emails registered with Frontiers:

Notify me on publication

Please enter your email address:

If you already have an account, please login

You don't have a Frontiers account ? You can register here

Mercè Cases 1 *, Rachel Giles 2 *, Tamás Ágh 3 , Maria Piggin 4 , Jan Geissler 1,5 , Monica Racovita 6 , Judit Hagymásy 3 , Lora Ruth Wogu 7 , Ákos Józwiak 3 , Albina Hyseni-Bocolli 8 , Dalma Hosszú 3,9 †, Ananda Plate 1,2 † and EuroACT Working Group

Keywords: Cancer, haematology, rare disease, Patient, Patient reported outcome, clinical trials

Received: 10 Nov 2025; Accepted: 11 Nov 2025.

Copyright: © 2025 Cases, Giles, Agh, Piggin, Geissler, Racovita, Hagymásy, Wogu, Józwiak, Hyseni-Bocolli, Hosszú and Plate. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Merce Cases, merce.cases@patientadvocacy.eu
Rachel Giles, rachelhelengiles@gmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Supplementary Material